Diego Based Immunoscape News Today : Breaking News, Live Updates & Top Stories | Vimarsana

San Diego-based ImmunoScape, a biotech company which says it is focused on discovery and development of next-generation TCR-T-cell therapeutics, has raised $14M in a funding round. The funding was led by A

Scape findsFrom amgenDiego based immunoscapeAnzu partnersAmgen ventures